With Seagen stock seemingly stuck in a downtrend, Virtus Investment Partners' Joe Terranova decided to cut his position. "Biotech, in this environment ...
News
- Seattle Genetics, Inc. (NASDAQ:SGEN) - Why This Investor Is Selling His Seagen Shares | Benzinga
- Cyrus Biotechnology makes acquisition after raising $18M - The Business Journals
On the heels of an $18 million Series B round, Seattle-based Cyrus Biotechnology said Monday it has acquired Orthogonal Biologics, a University of ...
- North Texas Inno - Canadian biotech firm plans Sachse manufacturing facility, hundreds of hires
A Canadian firm is joining North Texas' growing biotech scene. Evolve Biologics, a plasma-based therapeutics company, is set to break ground on a ...
- San Antonio International Airport exhibit gives veterans voice in song | TPR - Texas Public Radio
Veterans were paired with Nashville songwriters to take veterans' experiences and turn them into songs. Vets' photos and the words to the songs ...
- The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple ...
3, and biotech stocks did not escape the brunt of selling in the wake of the negative ... 2021 San Antonio Breast Cancer Symposium, SABCS: Dec.